No Prescription |
 |
 | ||
|
NICARDIA Adalat |
|
| ||
No Prescription » Prescription Drugs 11 » NICARDIA Adalat Nifedipine is used to treat high blood pressure. It relaxes your blood vessels so your heart does not have to pump as hard. It also increases the supply of blood and oxygen to the heart to control chest pain (angina). If taken regularly nifedipine controls chest pain but it does not stop chest pain once it starts. Your doctor may give you a different medication to take when you have chest pain.Nifedipine comes as a capsule and an extended-release tablet (long-acting) to take by mouth. It is usually taken one or three times a day. The extended-release tablet should be taken on an empty stomach either 1 hour before or 2 hours after a meal and should be swallowed whole. Do not chew divide or crush the tablet. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take nifedipine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Nifedipine controls high blood pressure and chest pain (angina) but does not cure them. Continue to take nifedipine even if you feel well. Do not stop taking nifedipine without talking to your doctor.Nifedipine is also used sometimes to treat migraine headaches Raynaud's syndrome congestive heart failure and cardiomyopathy. Buy NICARDIA Adalat and other Prescription Drugs 11 products online at Medstore. Buy Online at Medstore - Click Here!
About NICARDIA Adalat: Product Type: Prescription Drugs 11 NICARDIA ( Adalat Procardia Nifedecal Generic Nifedipine ) NICARDIA (Adalat Procardia Nifedecal Generic Nifedipine) Adalat Procardia Nifedecal Generic Nifedipine 10mg MR Tabs Adalat Procardia Nifedecal Generic Nifedipine NICARDIA
View more Prescription Drugs 11 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
